Skip to main content
. Author manuscript; available in PMC: 2013 Dec 19.
Published in final edited form as: Arthritis Rheum. 2009 Oct 15;61(10):10.1002/art.24642. doi: 10.1002/art.24642

Figure 2.

Figure 2

Forest plot of results of published studies on the association between HLA–B51/B5 and Behçet’s disease (BD) (listed chronologically). Odds ratios (ORs) for the risk of HLA–B51/B5 allele carriers to develop BD compared with noncarriers. The dashed vertical line indicates the pooled value for the entire population considered. *See Materials and Methods for a list of other criteria applied. 95% CI = 95% confidence interval; E = Eastern; Serol. = serologic; JBDRC = Japanese Behçet’s Disease Research Committee; N = North; M = Middle; NR = not reported; S = Southern; ISG = International Study Group; Molec. = molecular.